Skip to main content
. Author manuscript; available in PMC: 2021 Feb 17.
Published in final edited form as: J Infect Dis. 2008 May 15;197(10):1436–1447. doi: 10.1086/587698

Table 1.

Characteristics of human papillomavirus (HPV) infection among women from São Paulo, Brazil, by HPV type, phylogenetic relationship, and oncogenic risk.

HPV category Prevalence at enrollment, no. (%) of women (n = 2351a) Incident infections, no. of women Follow-up duration, women-months Incidence rate,b infections/1000 women-months (95% CI) Cleared infection, no. of women Follow-up duration, women-months Clearance rate, infections/1000 women-months (95% CI)
Type
 6/11   26 (1.1)   62 109,735 0.57 (0.44–0.72)   53   506 104.8 (80.1–137.2)
 16   64 (2.7) 189 104,559 1.81 (1.57–2.08) 148 1795 82.4 (70.2–96.8)
 18   26 (1.1)   52 109,960 0.47 (0.36–0.62)   46   501 91.9 (68.8–122.7)
 26  3 (0.1)   13 112,457 0.12 (0.07–0.20)  9  82 109.3 (56.9–210.1)
 31   29 (1.2)   56 109,718 0.51 (0.39–0.66)   43   539 79.8 (59.2–107.6)
 32  1 (0.0)  9 112,782 0.08 (0.04–0.15)  4  27 146.2 (54.9–389.4)
 33  9 (0.4)   31 111,271 0.28 (0.20–0.40)   26   400 65.0 (44.3–95.5)
 34  2 (0.1)  0 112,800 NA NA NA NA
 35  7 (0.3)   59 111,048 0.53 (0.41–0.69)   44   558 78.9 (58.7–106.0)
 39  3 (0.1)   31 112,075 0.28 (0.19–0.39)   22   298 73.9 (48.7–112.2)
 40  6 (0.3)   30 111,857 0.27 (0.19–0.38)   21   167 125.8 (82.1–193.0)
 42  1 (0.0)   23 112,524 0.20 (0.14–0.31)   13   159 81.8 (47.5–140.9)
 44  2 (0.1)  7 112,540 0.06 (0.03–0.13)  7  59 118.0 (56.3–247.6)
 45   13 (0.6)   48 110,931 0.43 (0.33–0.57)   38   414 91.9 (66.9–126.3)
 51   30 (1.3) 106 107,976 0.98 (0.81–1.19)   91 1045 87.0 (70.9–106.9)
 52   20 (0.9)   65 109,872 0.59 (0.46–0.75)   48   593 81.0 (61.0–107.4)
 53   39 (1.7) 109 107,273 1.02 (0.84–1.23)   91 1056 86.2 (70.2–105.8)
 54  8 (0.3)   52 110,945 0.47 (0.36–0.62)   42   439 95.6 (70.7–129.4)
 55   10 (0.4)   62 110,952 0.56 (0.44–0.72)   52   494 105.3 (80.3–138.2)
 56   13 (0.6)   46 111,326 0.41 (0.31–0.55)   32   410 78.1 (55.2–110.4)
 57 0   5 112,867 0.04 (0.02–0.11)  4  29 136.3 (51.2–363.2)
 58   27 (1.1)   68 109,536 0.62 (0.49–0.79)   52   721 72.1 (55.0–94.7)
 59   13 (0.6)   40 110,957 0.36 (0.26–0.49)   33   319 103.5 (73.6–145.6)
 61   18 (0.8)   32 110,842 0.29 (0.20–0.41)   26   273 95.1 (64.7–139.6)
 62  2 (0.1)   38 111,699 0.34 (0.25–0.47)   32   305 104.9 (74.2–148.3)
 64 0   0 112,900 NA NA NA NA
 66   10 (0.4)   33 111,600 0.30 (0.21–0.42)   27   209 129.4 (88.8–188.8)
 67 0   6 112,570 0.05 (0.02–0.12)  5  28 178.2 (74.2–428.1)
 68   15 (0.6)   47 110,797 0.42 (0.32–0.56)   41   368 111.3 (81.9–151.1)
 69 0   3 112,782 0.03 (0.01–0.08)  2  10 197.4 (49.4–789.3)
 70   18 (0.8)   23 111,380 0.21 (0.14–0.31)   17   140 121.8 (75.7–195.9)
 71  5 (0.2)   19 112,094 0.17 (0.11–0.27)   15   162 92.7 (55.9–153.7)
 72  6 (0.3)  6 112,360 0.05 (0.02–0.12)  5  39 127.4 (53.0–306.1)
 73   10 (0.4)   40 110,957 0.36 (0.26–0.49)   35   326 107.5 (77.2–149.7)
 81  9 (0.4)   20 111,794 0.18 (0.12–0.28)   16   159 100.6 (61.6–164.2)
 82  3 (0.1)   19 111,962 0.17 (0.11–0.27)   15   152 98.7 (59.5–163.7)
 83 0    34 111,805 0.30 (0.22–0.43)   29   297 97.6 (67.8–140.4)
 84   14 (0.6)   72 110,396 0.65 (0.52–0.82)   54   588 91.9 (70.4–119.9)
 89  1 (0.0)   16 112,360 0.14 (0.09–0.23)   16   127 126.5 (77.5–206.4)
Phylogenetic relationshipc
 Species 3   54 (2.3) 194 104,346 1.86 (1.62–2.14) 161 1655 97.3 (83.3–113.5)
 Species 5   34 (1.5) 132 106,770 1.24 (1.04–1.47) 109 1247 87.4 (72.5–105.5)
 Species 6   62 (2.6) 172 104,814 1.64 (1.41–1.91) 138 1598 86.4 (73.1–102.1)
 Species 7   85 (3.6) 199 102,683 1.94 (1.69–2.23) 164 1742 94.1 (80.8–109.7)
 Species 9 144 (6.1) 354 94,387 3.75 (3.38–4.16) 280 3661 76.5 (68.0–86.0)
 Species 10   36 (1.5) 122 107,612 1.13 (0.95–1.35) 104 1045 99.5 (82.1–120.6)
Oncogenic riskd
 Any 394 (16.8) 666 70,150 9.49 (8.80–10.24) 548 7368 74.4 (68.4–80.9)
 High
  Any 250 (10.6) 509 83,575 6.09 (5.58–6.64) 411 5459 75.3 (68.4–82.9)
  Except type 16 200 (8.5) 432 88,586 4.88 (4.44–5.36) 348 4516 77.1 (69.4–85.6)
  Except types 16 and 18 176 (7.5) 416 90,414 4.60 (4.18–5.07) 330 4232 78.0 (70.0–86.9)
 Low 144 (6.1) 450 90,893 4.95 (4.51–5.43) 379 4002 94.7 (85.6–104.7)

NOTE. CI, confidence interval; NA, not applicable.

a

Data exclude women who tested negative for both β-globin and HPV and women who were not tested.

b

Data exclude women who tested positive for HPV at baseline.

c

Data are for alpha-papillomavirus species. HPV types 61, 62, 72, 81, 83, 84, and 89 are classified as alpha-papillomavirus species 3; HPV types 26, 51, 69, and 82 as species 5; HPV types 53, 56, and 66 as species 6; HPV types 18, 39, 45, 59, 68, and 70 as species 7; HPV types 16, 31, 33, 35, 52, 58, and 67 as species 9; and HPV types 6/11, 44, and 55 as species 10.

d

See the text for descriptions of high-risk and low-risk HPV types.